JP Morgan Chase
ASXC

JP Morgan Chase’s Asensus Surgical, Inc. ASXC Stock Holding History

JP Morgan Chase’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,177
Closed -$541K – 5986
2018
Q3 		$541K Buy
+7,177
New +$486K ﹤0.01% 4242

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's ASXC Position: Q3 2024 in Review

JP Morgan Chase sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 87,506 shares — an estimated $29.1K sold.

JP Morgan Chase first reported a position in ASXC in Q2 2014 and held it in 36 quarters. The position peaked at $44.4M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • JP Morgan Chase reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • JP Morgan Chase sold 87,506 Asensus Surgical, Inc. shares in Q3 2024, an estimated $29.1K.
  • JP Morgan Chase first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 36 quarters.
  • JP Morgan Chase's Asensus Surgical, Inc. position peaked at $44.4M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.